Sarepta Therapeutics Stock Forecast - Double Exponential Smoothing

S1RP34 Stock  BRL 40.47  1.74  4.12%   
The Double Exponential Smoothing forecasted value of Sarepta Therapeutics on the next trading day is expected to be 41.12 with a mean absolute deviation of 0.72 and the sum of the absolute errors of 42.43. Sarepta Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Sarepta Therapeutics stock prices and determine the direction of Sarepta Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Sarepta Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
  
Double exponential smoothing - also known as Holt exponential smoothing is a refinement of the popular simple exponential smoothing model with an additional trending component. Double exponential smoothing model for Sarepta Therapeutics works best with periods where there are trends or seasonality.

Sarepta Therapeutics Double Exponential Smoothing Price Forecast For the 3rd of December

Given 90 days horizon, the Double Exponential Smoothing forecasted value of Sarepta Therapeutics on the next trading day is expected to be 41.12 with a mean absolute deviation of 0.72, mean absolute percentage error of 1.56, and the sum of the absolute errors of 42.43.
Please note that although there have been many attempts to predict Sarepta Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Sarepta Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Sarepta Therapeutics Stock Forecast Pattern

Backtest Sarepta TherapeuticsSarepta Therapeutics Price PredictionBuy or Sell Advice 

Sarepta Therapeutics Forecasted Value

In the context of forecasting Sarepta Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Sarepta Therapeutics' downside and upside margins for the forecasting period are 37.71 and 44.53, respectively. We have considered Sarepta Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
40.47
41.12
Expected Value
44.53
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Double Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Sarepta Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Sarepta Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information CriteriaHuge
BiasArithmetic mean of the errors -0.2163
MADMean absolute deviation0.7192
MAPEMean absolute percentage error0.02
SAESum of the absolute errors42.4341
When Sarepta Therapeutics prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any Sarepta Therapeutics trend in the prices. So in double exponential smoothing past observations are given exponentially smaller weights as the observations get older. In other words, recent Sarepta Therapeutics observations are given relatively more weight in forecasting than the older observations.

Predictive Modules for Sarepta Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sarepta Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.003.41
Details
Intrinsic
Valuation
LowRealHigh
0.000.003.41
Details
Bollinger
Band Projection (param)
LowMiddleHigh
29.7935.7241.65
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Sarepta Therapeutics. Your research has to be compared to or analyzed against Sarepta Therapeutics' peers to derive any actionable benefits. When done correctly, Sarepta Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Sarepta Therapeutics.

Other Forecasting Options for Sarepta Therapeutics

For every potential investor in Sarepta, whether a beginner or expert, Sarepta Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Sarepta Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Sarepta. Basic forecasting techniques help filter out the noise by identifying Sarepta Therapeutics' price trends.

Sarepta Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sarepta Therapeutics stock to make a market-neutral strategy. Peer analysis of Sarepta Therapeutics could also be used in its relative valuation, which is a method of valuing Sarepta Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Sarepta Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Sarepta Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Sarepta Therapeutics' current price.

Sarepta Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Sarepta Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sarepta Therapeutics shares will generate the highest return on investment. By undertsting and applying Sarepta Therapeutics stock market strength indicators, traders can identify Sarepta Therapeutics entry and exit signals to maximize returns.

Sarepta Therapeutics Risk Indicators

The analysis of Sarepta Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Sarepta Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting sarepta stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Information and Resources on Investing in Sarepta Stock

When determining whether Sarepta Therapeutics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Sarepta Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Sarepta Therapeutics Stock. Highlighted below are key reports to facilitate an investment decision about Sarepta Therapeutics Stock:
Check out Historical Fundamental Analysis of Sarepta Therapeutics to cross-verify your projections.
For information on how to trade Sarepta Stock refer to our How to Trade Sarepta Stock guide.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Please note, there is a significant difference between Sarepta Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sarepta Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sarepta Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.